These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7875216

  • 1. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
    Lu Y, Phillips CA, Trevillyan JM.
    Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
    [Abstract] [Full Text] [Related]

  • 2. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
    Lu Y, Rodriguez R, Bjorndahl J, Phillips CA, Trevillyan JM.
    Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
    [Abstract] [Full Text] [Related]

  • 3. CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca(2+)-independent costimulatory activity.
    Lu Y, Phillips CA, Bjorndahl JM, Trevillyan JM.
    Eur J Immunol; 1994 Nov; 24(11):2732-9. PubMed ID: 7957566
    [Abstract] [Full Text] [Related]

  • 4. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M, Battifora M, Truneh A, Waterfield MD, Olive D.
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [Abstract] [Full Text] [Related]

  • 5. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase.
    Truitt KE, Shi J, Gibson S, Segal LG, Mills GB, Imboden JB.
    J Immunol; 1995 Nov 15; 155(10):4702-10. PubMed ID: 7594470
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin.
    Ward SG, Wilson A, Turner L, Westwick J, Sansom DM.
    Eur J Immunol; 1995 Feb 15; 25(2):526-32. PubMed ID: 7875215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structural requirements for CD28-mediated costimulation of IL-2 production in Jurkat T cells.
    Truitt KE, Nagel T, Suen LF, Imboden JB.
    J Immunol; 1996 Jun 15; 156(12):4539-41. PubMed ID: 8648094
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
    Soares LR, Rivas A, Tsavaler L, Engleman EG.
    J Immunol; 1997 Aug 01; 159(3):1115-24. PubMed ID: 9233604
    [Abstract] [Full Text] [Related]

  • 12. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y, Levine BL, Huang ML, Freeman GJ, Nadler LM, June CH, Ward SG.
    Int Immunol; 1995 Jun 01; 7(6):957-66. PubMed ID: 7577804
    [Abstract] [Full Text] [Related]

  • 13. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
    Lu Y, Granelli-Piperno A, Bjorndahl JM, Phillips CA, Trevillyan JM.
    J Immunol; 1992 Jul 01; 149(1):24-9. PubMed ID: 1318900
    [Abstract] [Full Text] [Related]

  • 14. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling.
    Pagès F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J, Olive D.
    Nature; 1994 May 26; 369(6478):327-9. PubMed ID: 8183372
    [Abstract] [Full Text] [Related]

  • 15. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL, Phu T, Butler JJ, Makrigiannis AP, Hoskin DW.
    Exp Cell Res; 1999 Oct 10; 252(1):96-103. PubMed ID: 10502402
    [Abstract] [Full Text] [Related]

  • 16. Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells.
    Ni HT, Deeths MJ, Mescher MF.
    J Immunol; 1996 Sep 15; 157(6):2243-6. PubMed ID: 8805620
    [Abstract] [Full Text] [Related]

  • 17. MIP-1alpha induces activation of phosphatidylinositol-3 kinase that associates with Pyk-2 and is necessary for B-cell migration.
    Rumsey LM, Teague RM, Benedict SH, Chan MA.
    Exp Cell Res; 2001 Aug 01; 268(1):77-83. PubMed ID: 11461120
    [Abstract] [Full Text] [Related]

  • 18. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production.
    Marquardt DL, Alongi JL, Walker LL.
    J Immunol; 1996 Mar 01; 156(5):1942-5. PubMed ID: 8596048
    [Abstract] [Full Text] [Related]

  • 19. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.
    Teng JM, Liu XR, Mills GB, Dupont B.
    J Immunol; 1996 May 01; 156(9):3222-32. PubMed ID: 8617944
    [Abstract] [Full Text] [Related]

  • 20. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y, Angelotti T, Niederfellner G, Herbst R, Ullrich A.
    Cell Growth Differ; 1998 Mar 01; 9(3):247-56. PubMed ID: 9543391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.